Jane Street’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318K Sell
42,900
-79,200
-65% -$833K ﹤0.01% 9112
2025
Q4
$1.44M Sell
122,100
-16,500
-12% -$178K ﹤0.01% 5407
2025
Q3
$1.07M Buy
138,600
+44,200
+47% +$310K ﹤0.01% 6163
2025
Q2
$690K Buy
94,400
+13,400
+17% +$108K ﹤0.01% 6328
2025
Q1
$769K Buy
81,000
+18,100
+29% +$226K ﹤0.01% 6054
2024
Q4
$1.04M Buy
62,900
+10,400
+20% +$162K ﹤0.01% 5318
2024
Q3
$774K Buy
52,500
+6,800
+15% +$106K ﹤0.01% 6395
2024
Q2
$634K Sell
45,700
-12,400
-21% -$176K ﹤0.01% 6632
2024
Q1
$913K Buy
58,100
+8,400
+17% +$130K ﹤0.01% 5581
2023
Q4
$804K Sell
49,700
-21,100
-30% -$345K ﹤0.01% 5964
2023
Q3
$871K Sell
70,800
-22,900
-24% -$341K ﹤0.01% 5400
2023
Q2
$1.51M Sell
93,700
-167,200
-64% -$2.76M ﹤0.01% 4594
2023
Q1
$4.54M Buy
260,900
+222,300
+576% +$3.17M ﹤0.01% 2591
2022
Q4
$357K Sell
38,600
-37,500
-49% -$350K ﹤0.01% 6719
2022
Q3
$655K Buy
76,100
+12,300
+19% +$122K ﹤0.01% 6185
2022
Q2
$520K Sell
63,800
-29,400
-32% -$281K ﹤0.01% 6667
2022
Q1
$1.13M Buy
93,200
+62,500
+204% +$1.32M ﹤0.01% 5879
2021
Q4
$1.05M Sell
30,700
-14,100
-31% -$552K ﹤0.01% 5808
2021
Q3
$2.16M Buy
44,800
+22,100
+97% +$1.02M ﹤0.01% 4322
2021
Q2
$1.02M Sell
22,700
-14,100
-38% -$625K ﹤0.01% 5783
2021
Q1
$1.77M Sell
36,800
-700
-2% -$36.4K ﹤0.01% 4250
2020
Q4
$2.02M Buy
37,500
+21,100
+129% +$953K ﹤0.01% 3468
2020
Q3
$605K Sell
16,400
-12,300
-43% -$457K ﹤0.01% 4858
2020
Q2
$889K Buy
+28,700
New +$795K ﹤0.01% 4238

Other funds holding NEO

Jane Street's NEO Position: Q1 2026 in Review

Jane Street sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 114,016 shares — an estimated $1.2M sold.

Jane Street first reported a position in NEO in Q4 2018 and held it in 22 quarters. The position peaked at $4.83M in Q2 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Jane Street reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 114,016 NeoGenomics shares in Q1 2026, an estimated $1.2M.
  • Jane Street first reported a position in NeoGenomics in Q4 2018 and held it in 22 quarters.
  • Jane Street's NeoGenomics position peaked at $4.83M in Q2 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.